Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma
Raza S. Hoda, Edi Brogi, Carlos Henrique dos Anjos, Anne Grabenstetter, Katia Ventura, Sujata Patil, Pier Selenica, Britta Weigelt, Jorge S. Reis‐Filho, Tiffany A. Traina, Mark E. Robson, Larry Norton, Hannah Y. Wen
Topics & Concepts
AtezolizumabTriple-negative breast cancerImmunohistochemistryStromal cellPD-L1MedicinePathologyMetastatic Urothelial CarcinomaOncologyBreast cancerCancer researchInternal medicineCancerImmunotherapyNivolumabUrothelial carcinomaBladder cancerCancer Immunotherapy and BiomarkersCancer Cells and MetastasisCancer Genomics and Diagnostics